A Multicenter Observational Study of Whole Genome Analysis for patient benefit
Not Applicable
Recruiting
- Conditions
- cancer
- Registration Number
- JPRN-UMIN000049428
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients with advanced or refractory cancer linked to treatment after whole genome analysis
- Secondary Outcome Measures
Name Time Method Percentage of patients who will be diagnosed after whole genome analysis in particularly difficult-to-diagnose cancer types, including rare cancers. Percentage of patients for whom a heritable disease-associated pathological variant is extracted by whole genome analysis